You are here

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership

NORTH BRUNSWICK, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and manufacture four prescription generic pharmaceutical products that are intended to be commercialized in the U.S. under the Oakrum label. It is anticipated that the products will serve the retail market and will include oral solutions and topicals. The total addressable market exceeded $300 million in the aggregate for the 12-month period ending December 31, 2018, according to available data from IQVIA.
Tuesday, February 19, 2019 - 08:00